Agape Deferred Long Term Liab from 2010 to 2024

ATPC Stock   1.55  0.01  0.64%   
Agape ATP's Deferred Long Term Liabilities is increasing over the years with slightly volatile fluctuation. Deferred Long Term Liabilities is expected to dwindle to about 282.8 K. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2010-12-31
Previous Quarter
304.4 K
Current Value
282.8 K
Quarterly Volatility
16.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Agape ATP financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agape ATP's main balance sheet or income statement drivers, such as Selling And Marketing Expenses of 589.2 K, Other Operating Expenses of 2.4 M or Total Operating Expenses of 1.8 M, as well as many indicators such as Price To Sales Ratio of 32.21, Dividend Yield of 0.0 or PTB Ratio of 11.66. Agape financial statements analysis is a perfect complement when working with Agape ATP Valuation or Volatility modules.
  
Check out the analysis of Agape ATP Correlation against competitors.
For information on how to trade Agape Stock refer to our How to Trade Agape Stock guide.

Latest Agape ATP's Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of Agape ATP over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Agape ATP's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agape ATP's overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

Agape Deferred Long Term Liab Regression Statistics

Arithmetic Mean257,436
Geometric Mean256,997
Coefficient Of Variation6.27
Mean Deviation11,602
Median249,525
Standard Deviation16,147
Sample Variance260.7M
Range54.9K
R-Value0.69
Mean Square Error146.3M
R-Squared0.48
Significance0
Slope2,499
Total Sum of Squares3.7B

Agape Deferred Long Term Liab History

2024282.8 K
2023304.4 K
2021264.7 K

About Agape ATP Financial Statements

Agape ATP stakeholders use historical fundamental indicators, such as Agape ATP's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Agape ATP investors may analyze each financial statement separately, they are all interrelated. For example, changes in Agape ATP's assets and liabilities are reflected in the revenues and expenses on Agape ATP's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Agape ATP. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities304.4 K282.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Agape ATP offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agape ATP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agape Atp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agape Atp Stock:
Check out the analysis of Agape ATP Correlation against competitors.
For information on how to trade Agape Stock refer to our How to Trade Agape Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agape ATP. If investors know Agape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agape ATP listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.73)
Revenue Per Share
0.36
Quarterly Revenue Growth
0.03
Return On Assets
(0.51)
Return On Equity
(1.22)
The market value of Agape ATP is measured differently than its book value, which is the value of Agape that is recorded on the company's balance sheet. Investors also form their own opinion of Agape ATP's value that differs from its market value or its book value, called intrinsic value, which is Agape ATP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agape ATP's market value can be influenced by many factors that don't directly affect Agape ATP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agape ATP's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agape ATP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agape ATP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.